Investigating how maternal health affects childhood obesity and cardiometabolic disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows mothers and their children from two Finnish pregnancy cohorts to explore the links between maternal health conditions, such as obesity and gestational diabetes, and the subsequent health outcomes in their children. The study will assess various factors, including body composition and cardiovascular health, in children aged 11-17 years. Data will be collected through detailed health assessments and metabolomic analyses to understand the impact of maternal conditions on child health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* all mothers participated originally in the PREDO or the RADIEL studies during pregnancy and with delivery during this index pregnancy

Exclusion Criteria:

\-

Where it's running

• Saila Koivusalo
  Helsinki, Finland Recruiting

Study contacts

• Study coordinator: Saila B Koivusalo, prof
• Email: saila.koivusalo@hus.fi
• Phone: +358407250620

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Genotype-guided approach to improve cardiometabolic health using natriuretic peptides

  This study is testing if a special approach using natriuretic peptides can help improve heart and metabolic health in adults with a certain genetic variant that leads to lower levels of these peptides.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT05216042

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.